Nymalize

Product manufactured by Arbor Pharmaceuticals

Application Nr Approved Date Route Status External Links
NDA203340 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nymalize Is Indicated For The Improvement Of Neurological Outcome By Reducing The Incidence And Severity Of Ischemic Deficits In Adult Patients With Subarachnoid Hemorrhage (Sah) From Ruptured Intracranial Berry Aneurysms Regardless Of Their Post-Ictus Neurological Condition (I.e., Hunt And Hess Grades I-V). Nymalize Is A Dihydropyridine Calcium Channel Blocker Indicated For The Improvement Of Neurological Outcome By Reducing The Incidence And Severity Of Ischemic Deficits In Adult Patients With Subarachnoid Hemorrhage (Sah) From Ruptured Intracranial Berry Aneurysms Regardless Of Their Post-Ictus Neurological Condition (I.e., Hunt And Hess Grades I-V). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Nimodipine NIMODIPINE ZINC19632713

Comments